Darren Hartley Bondar Purchases 310,474 Shares of Hempalta Corp. (CVE:HEMP) Stock
Hempalta Corp. (CVE:HEMP – Get Free Report) Director Darren Hartley Bondar purchased 310,474 shares of the stock in a transaction that occurred on Tuesday, December 24th. The stock was acquired at an average cost of C$0.05 per share, with a total value of C$14,499.14. Darren Hartley Bondar also recently made the following trade(s): On Tuesday, […]
More Stories
Head to Head Survey: Integra LifeSciences (NASDAQ:IART) & Alpha Tau Medical (NASDAQ:DRTS)
Alpha Tau Medical (NASDAQ:DRTS – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical...
Zoetis Inc. (NYSE:ZTS) Receives Consensus Recommendation of “Buy” from Analysts
Zoetis Inc. (NYSE:ZTS – Get Free Report) has been assigned an average recommendation of “Buy” from the eleven ratings firms...
Reinsurance Group of America, Incorporated (NYSE:RGA) Receives Average Recommendation of “Moderate Buy” from Analysts
Reinsurance Group of America, Incorporated (NYSE:RGA – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by...
Analysts Set Health Catalyst, Inc. (NASDAQ:HCAT) Price Target at $11.79
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has received an average recommendation of “Moderate Buy” from the twelve analysts...
Genmab A/S (NASDAQ:GMAB) Receives $45.20 Average Price Target from Analysts
Shares of Genmab A/S (NASDAQ:GMAB – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the...
Brokerages Set Invesco Ltd. (NYSE:IVZ) Target Price at $18.63
Invesco Ltd. (NYSE:IVZ – Get Free Report) has received an average recommendation of “Hold” from the twelve research firms that...